Clinical trial
Safety and Tolerability of Herpes Zoster Vaccine in Patients With Rheumatoid Arthritis Immunized Prior to Biologics and Tofacitinib Therapy Initiation
NCT03016884 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerability of Herpes Zoster Vaccine in Patients With Rheumatoid Arthritis Immunized Prior to Biologics and Tofacitinib Therapy Initiation
- Lead sponsor
- HaEmek Medical Center, Israel
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- July 31, 2020
- Enrollment
- 87 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.